Matthew A.K. Inlay
Affiliations: | 2004-2012 | Stanford University School of Medicine, Palo Alto, CA, United States | |
| 2013- | University of California, Irvine, Irvine, CA |
Website:
https://stemcell.uci.edu/People/Faculty/matthew_a_inlay.phpGoogle:
"Matthew Arthur Kalani Inlay" OR "Matthew A.K. Inlay"Bio:
https://books.google.com/books?id=gQPxiqlbd_MC
https://books.google.com/books?id=hcITAQAAMAAJ
Parents
Sign in to add mentor| Yang Xu | grad student | 2003 | UCSD | |
| (Roles of the immunoglobulin kappa light chain enhancers in regulating kappa rearrangement.) | ||||
| Irving L. Weissman | post-doc | 2004-2012 | Stanford Medical School | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Karimzadeh A, Varady ES, Scarfone VM, et al. (2021) Absence of CD11a Expression Identifies Embryonic Hematopoietic Stem Cell Precursors Competitive Neonatal Transplantation Assay. Frontiers in Cell and Developmental Biology. 9: 734176 |
| Pavel-Dinu M, Wiebking V, Dejene BT, et al. (2019) Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nature Communications. 10: 5624 |
| Pavel-Dinu M, Wiebking V, Dejene BT, et al. (2019) Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nature Communications. 10: 2021 |
| Pavel-Dinu M, Wiebking V, Dejene BT, et al. (2019) Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nature Communications. 10: 1634 |
| Varady E, Inlay M. (2019) BONE MARROW TRANSPLANTATION, A POSSIBLE THERAPY FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA Experimental Hematology. 76: S90 |
| Karimzadeh A, Scarfone VM, Varady E, et al. (2018) The CD11a and Endothelial Protein C Receptor Marker Combination Simplifies and Improves the Purification of Mouse Hematopoietic Stem Cells. Stem Cells Translational Medicine |
| Ghorbanian Y, Lee L, Mikkola H, et al. (2018) Lyve1-Derived Hematopoietic Stem Cells are Intrinsically Different in Their Lineage Output Than Other HSCs Experimental Hematology. 64: S67 |
| Shukla A, Inlay M. (2018) Hematopoietic Stem Cells Derived From Extra-Embryonic Mesoderm Experimental Hematology. 64: S103 |
| Ghorbanian Y, Lee L, Mikkola H, et al. (2017) Tracing the emergence of hematopoietic stem cells from the extra-embryonic yolk sac Experimental Hematology. 53: S104 |
| Lee LK, Ghorbanian Y, Wang W, et al. (2016) LYVE1 Marks the Divergence of Yolk Sac Definitive Hemogenic Endothelium from the Primitive Erythroid Lineage. Cell Reports. 17: 2286-2298 |